Capgemini : Q1 2017: Capgemini starts the year on a solid

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
192
Capgemini : Q1 2017: Capgemini starts the year on a solid footing

     

Media relations: Florence Lièvre Tel.: +33 1 47 54 50 71 florence.lievre@capgemini.com

Investor relations: Vincent Biraud Tel.: +33 1 47 54 50 87 vincent.biraud@capgemini.com

Q1 2017: Capgemini starts the year on a solid footing

Paris, April 26, 2017 - Capgemini Group achieved consolidated revenues of €3,171 million in the first quarter of 2017, up 2.8% year-on-year at constant exchange rates*.

For Paul Hermelin, Chairman and Chief Executive Officer of Capgemini Group: "We start the year on a solid footing. Our revenue growth of 2.8% in Q1 is driven by a strong momentum in Continental Europe and an improved performance in North America. Financial Services and Manufacturing - which together account for nearly half of the Group's revenues - show growth rates close to 10%. This reflects our ability to support key market players in their digital transformation. In addition, a strong level of bookings confirms the good start to the year.

Digital and Cloud grew 24% year-on-year and now account for 32% of our revenues. We completed three focused acquisitions this quarter, aimed at further expanding our portfolio in these areas and bringing innovative and end-to-end digital solutions to our clients: Idean, a digital design firm based in Palo Alto, Atlanta-based TCube Solutions, specialized in Duck Creek Technologies insurance software and Itelios, an omni-channel e-commerce expert.

We are also investing in our automation platforms and our global production centers to accompany our clients in their drive to improve competitiveness.

By continuing to implement our strategic priorities, we demonstrate our ability to achieve all our objectives for 2017, the year of Capgemini's 50 th anniversary."

  (In millions of euros)   Change
  Q1 2016 Q1 2017   As reported At constant exchange rates * At constant exchange rates and Group scope *
Revenues 3,092 3,171   +2.6% +2.8% +2.6%

Q1 revenues totaled €3,171 million, up 2.6% year-on-year on a reported basis. At constant exchange rates * , revenue grew 2.8% after adjusting for the Brazilian equipment resale business which is being discontinued.

OPERATIONS BY BUSINESS

Consulting Services (4% of Group revenues), driven by growth in Continental Europe and fueled by digital transformation demand, reported year-on-year revenue growth of 10.6% at constant exchange rates. Technology & Engineering Services (16% of Group revenues) grew 5.0% at constant exchange rates, progressing across all Group regions, with a return to growth in France amplified by the positive impact of the number of working days this quarter. Application Services (61% of Group revenues) benefitted from a strong market demand for digital and cloud-based application offerings and continue to drive Group momentum, with revenue growth of 5.3%. Other Managed Services (19% of Group revenues) reported revenues down by 7.6%. This is entirely attributable to Infrastructure Services which continue to be impacted by the anticipated decline in the UK public sector. Business Services (Business Process Outsourcing and platforms) are stable in Q1.

OPERATIONS BY MAJOR REGION

In Q1, as planned, North America began to restore its growth momentum, with revenues almost stable year-on-year, at -0.2% at constant exchange rates, a marked improvement on the -3.1% reported in Q4 2016. In this region, the Energy & Utilities sector confirmed its path to recovery, with a third quarter of sequential revenue stability, while the Financial Services sector enjoyed good momentum and the Manufacturing sector strengthened. The United Kingdom and Ireland reported a revenue decline of 7.6% at constant exchange rates, reflecting the anticipated decline in the public sector while private sector remains healthy. France grew 5.2%, with almost 10% increase in Financial Services and Manufacturing, as well as in the consumer sectors (Commerce, Distribution, Telecom, etc.). The Rest of Europe enjoyed revenue growth of 7.8%, with around 10% increase in Germany, Scandinavia and Italy and positive growth in Benelux. Finally, the Asia-Pacific and Latin America region grew 13.6%, with activity slightly down in Latin America (excluding the Brazilian equipment resale business) and strong growth in Asia-Pacific.

HEADCOUNT

At March 31, 2017, the Group's total headcount stood at 195,800, up 7% year-on-year, with 111,300 employees in offshore centers (57% of the total headcount).

BOOKINGS

Bookings totaled €3,001 million in Q1 2017, down 3.2% at constant exchange rates on Q1 2016 which benefited from the renewal of a major multi-year contract in the UK public sector.

OUTLOOK FOR 2017

For 2017, the Group forecasts revenue growth at constant exchange rates of 3.0%, an operating margin of 11.7% to 11.9% and organic free cash flow generation in excess of €950 million.

In addition:

  • The Group expects the impact of currency movements on revenues to be limited on a full year basis, with the impact of the pound sterling depreciation against the euro offsetting notably the appreciation of the US dollar and the Brazilian real;
  • The Group has decided to discontinue its equipment resale activity in Brazil, which represented approximately €60 million in 2016. In order not to disrupt the analysis of quarterly trends, organic growth and growth at constant exchange rates are presented after removing this activity from 2016 and 2017 revenues;
  • The impact of acquisitions on revenue growth is estimated at this stage to be a few tens of basis points.

CONFERENCE CALL

Paul Hermelin, Chairman and Chief Executive Officer and Aiman Ezzat, Chief Financial Officer, will present this press release during a conference call in English to be held today at 8 a.m. Paris time (CET) . You can follow this conference call live via webcast at the following link . A replay will also be available for a period of one year.

All documents relating to this publication will be placed online on the Capgemini investor website at https://www.capgemini.com/results .

SCHEDULE

May 10, 2017         Combined Shareholders' Meeting July 27, 2017         Publication of H1 2017 results

DISCLAIMER

This press release may contain forward-looking statements.  Such statements may include projections, estimates, assumptions, statements regarding plans, objectives, intentions and/or expectations with respect to future financial results, events, operations and services and product development, as well as statements, regarding future performance or events. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans", "projects", "may", "would" "should" or the negatives of these terms and similar expressions. Although Capgemini's management currently believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking statements are subject to various risks and uncertainties (including without limitation risks identified in Capgemini's Registration Document available on Capgemini's website), because they relate to future events and depend on future circumstances that may or may not occur and may be different from those anticipated, many of which are difficult to predict and generally beyond the control of Capgemini. Actual results and developments may differ materially from those expressed in, implied by or projected by forward-looking statements.  Forward-looking statements are not intended to and do not give any assurances or comfort as to future events or results.  Other than as required by applicable law, Capgemini does not undertake any obligation to update or revise any forward-looking statement.

This press release does not contain or constitute an offer of securities for sale or an invitation or inducement to invest in securities in France, the United States or any other jurisdiction.

In this disclaimer, the term "Capgemini" refers to Cap Gemini SA, its affiliates and their respective directors, managers and employees.

ABOUT CAPGEMINI

With more than 190,000 people, Capgemini is present in over 40 countries and celebrates its 50 th Anniversary year in 2017. A global leader in consulting, technology and outsourcing services, the Group reported 2016 global revenues of EUR 12.5 billion. Together with its clients, Capgemini creates and delivers business, technology and digital solutions that fit their needs, enabling them to achieve innovation and competitiveness. A deeply multicultural organization, Capgemini has developed its own way of working, the Collaborative Business Experience TM , and draws on Rightshore ® , its worldwide delivery model. Learn more about us at  www.capgemini.com .

Rightshore ®  is a trademark belonging to Capgemini

APPENDIX

DEFINITIONS

Organic growth , or like-for-like growth, in revenues is the growth rate calculated at constant Group scope and exchange rates . The Group scope and exchange rates used are those for the published fiscal year. Exchange rates for the published fiscal year are also used to calculate growth at constant exchange rates .

As announced on the publication of the outlook for 2017, to ensure that the discontinuation of equipment resale activities in Brazil does not disrupt the analysis of quarterly trends, organic growth and growth at constant exchange rates will be presented after removing this activity from 2016 and 2017 revenues.

Growth rates reconciliation
Organic growth +2.6%
Changes in Group scope +0.2pt
Growth at constant exchange rates +2.8%
Exchange rates fluctuations +0.2pt
Current growth +3.0%
Activities being discontinued -0.4pt
Reported growth +2.6%

The impact from currencies is primarily due to the appreciation of the Brazilian real, the US dollar and the Canadian dollar and the depreciation of the pound sterling. The impact of discontinued activities is linked to evolution of the equipment resale business in Brazil, which in the first quarter of 2016 represented 18 million euros at the reported rate.

RESULTS BY REGION

  Revenues   Change
  Q1 2016 (In millions of euros) Q1 2017 (In millions of euros)   At constant exchange rates As reported
North America 938 972   -0.2% +3.6%
United Kingdom and Ireland 525 435   -7.6% -17.1%
France 633 666   +5.2% +5.2%
Rest of Europe 780 841   +7.8% +7.9%
Asia-Pacific and Latin America 216 257   +13.6% +18.9%
TOTAL 3,092 3,171   +2.8% +2.6%

OPERATIONS BY BUSINESS

  % of revenues   Change
  Q1 2016 Q1 2017   At constant exchange rates
Consulting services 4% 4%   +10.6%
Technology & Engineering Services 15% 16%   +5.0%
Application services 59% 61%   +5.3%
Other managed services 22% 19%   -7.6%
TOTAL 100% 100%   +2.8%

UTILIZATION RATES

  Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017
Consulting services 70% 71% 68% 70% 71%
Technology & Engineering Services 82% 83% 83% 83% 82%
Application services 81% 81% 82% 81% 81%

* The terms and non-GAAP measures marked with an (*) are defined and/or reconciled in the appendix to this press release.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...96ce05e06e

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CatsOnly: Building Community with Feline-Centric Care

Updated Category News Views 36

Cats Only: Not Just Another Vet Office Sometimes, a new kind of passion-driven initiative gets your attention. That's where CatsOnly™ steps in—a feline-exclusive clinic that’s not about the bottom line but about building connections and elevating that ultimate feline care game. Their latest gig, dubbed Ginger’s Giving Season, is all about bridging the gap between...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 94

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading
Kia's Landmark Triple Win at 2026 Car Awards

Updated Category News Views 85

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

Continue Reading
Resideo's AI-Powered Pro-IQ™ Predict: HVAC Revolution

Updated Category News Views 314

Is AI the Savior for HVAC Breakdowns? You ever been stuck on a freezing night with a busted heater? It's a classic tale: equipment goes south just when you need it most. But what if someone told you AI could catch HVAC issues before they send you running for the wool socks? Enter Resideo Technologies' latest brainchild, Pro-IQ™ Predict. This isn't some run-of-the-mill...

Continue Reading
Florida's Insurance Premiums: Why They Keep Skyrocketing

Updated Category News Views 61

What’s Driving Up These Premiums? If you’ve ever felt like your wallet gets lighter every time you pay your insurance premium, welcome to the club. It seems like the cost of insurance in Florida is like a runaway train. But don't just blame the hurricanes. Yeah, they definitely play their part, but there’s a bigger picture lurking behind those price tags. Weather...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 165

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
Ceipal Ora: AI Revolution for Staffing Firms Begins

Updated Category News Views 65

Staffing Game Changer: Enter Ceipal Ora Folks in the staffing arena, hold onto your hats—Ceipal's rolling out something that could turn the tables. This new AI hotshot, Ceipal Ora, claims to be not just another AI patch on an old coat but the whole new garment itself. It's not just some afterthought glued to a platform; it's the glue holding the operations together,...

Continue Reading
CeQur Revolutionizes Insulin Delivery with Wearable Patch

Updated Category News Views 67

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Continue Reading
Yeastar 2026 Summit: AI, Growth, and Global Vision

Updated Category News Views 32

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Continue Reading
Otus Earns Top Spot in Education AI at Innovation Awards

Updated Category News Views 85

Acknowledging AI's Growing Role in Education Times are changing, and the classroom ain't what it used to be. Enter Otus, a platform that's breaking the mold by bringing artificial intelligence smack dab into K-12 education. They've bagged the 2026 SmartBrief Innovation Award in AI within the Education category. Clocking in at serving nearly 100 school districts, it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Canine Cancer Treatment Through Innovation

Updated Category News Views 167

Revolutionizing Canine Cancer Care Through Innovation The world of veterinary medicine has seen incredible progress in caring for dogs with cancer. Thrive Pet Healthcare is making significant efforts to improve the quality of care for these pets. Their partnership with FidoCure, a leader in canine oncology, highlights their dedication to helping pet owners access...

Continue Reading
BioAtla to Showcase Innovative Cancer Therapies at Major Events

Updated Category News Views 189

BioAtla to Showcase Innovative Cancer Therapies at Major Events BioAtla, Inc. (Nasdaq: BCAB), a prominent player in the biotechnology sector, focuses on advancing Conditionally Active Biologic (CAB) antibody therapeutics aimed at treating solid tumors. With a commitment to innovation and patient care, the company announced that two of its research abstracts have been...

Continue Reading
Liberty Star Minerals' Geophysical Breakthrough in Gold Discovery

Updated Category News Views 158

Revelation in Gold Exploration Liberty Star Minerals, an innovative exploration company, has recently made headlines with the successful induced polarization (IP) and resistivity testing at the Red Rock Canyon Gold Project. This project is a part of their extensive Hay Mountain Project in southeastern Arizona. These tests are pivotal in the ongoing search for strategic...

Continue Reading
Malibu Boats Celebrates Another Award for the Wakesetter 23 LSV

Updated Category News Views 135

Malibu Boats Wakesetter 23 LSV Triumphs Again Malibu Boats, Inc. (NASDAQ: MBUU) continues to solidify its position as the leader in the watersports boating industry. The iconic Malibu Wakesetter 23 LSV has been awarded the prestigious title of Wakesurf and Wakeboard Boat of the Year for the sixth consecutive year by the WakeWorld Riders Choice Awards. This remarkable...

Continue Reading
Alto Neuroscience Faces Deadline for Securities Fraud Lawsuit

Updated Category News Views 100

Understanding Alto Neuroscience's Legal Challenges Alto Neuroscience, Inc. (NYSE: ANRO) is currently in the spotlight due to a securities fraud class action lawsuit filed on behalf of its investors. The company has faced scrutiny regarding its initial public offering (IPO) and claims that misrepresentations were made about its flagship product, ALTO-100, a treatment...

Continue Reading